Advertisement
Trending - Altmetric
-
The search for CDK4/6 inhibitor biomarkers has been hampered by inappropriate proliferation assays
-
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
-
Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models
-
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer